Patient-Friendly Explanation
Qsymia is a prescription weight loss medication that combines two drugs — phentermine, which suppresses appetite, and topiramate, which helps you feel fuller for longer. This combination has been shown to produce greater weight loss than either drug alone. It is typically prescribed alongside diet and exercise for people with obesity or weight-related health conditions.
Clinical Definition
Phentermine-topiramate extended-release (Qsymia) is a fixed-dose combination pharmacotherapy approved for chronic weight management. Phentermine is a sympathomimetic amine that promotes norepinephrine release in the hypothalamus, suppressing appetite. Topiramate’s weight loss mechanism is multifactorial — it enhances GABAergic activity, inhibits carbonic anhydrase (altering taste perception), and increases energy expenditure. In the EQUIP and CONQUER trials, the top dose (15 mg/92 mg) produced mean weight loss of 10-11% at one year versus 1-2% for placebo.
Why It Matters
Qsymia offers one of the highest weight loss efficacies among oral anti-obesity medications. At NuLifeCare Singapore, our doctors can assess whether this combination is appropriate for your individual health profile as part of a medically supervised weight management programme.